AccuSave is a patented low-dead-space syringe and interchangeable needle system designed to reduce medication waste and improve dosing precision in high-value injectable therapies. Built on a proprietary reverse Luer-lock architecture with an integrated obturating needle spike, it minimizes dead space in both the syringe tip and needle hub, improving drug delivery efficiency compared to conventional syringe designs.

Optimized for neurotoxin injections such as Botox, AccuSave is also compatible with dermal fillers, vaccines, biologics, GLP-1 medications, and other high-cost injectable liquids and gels.

Unlike standard 1cc and insulin syringes adapted from general medical use, AccuSave is engineered for unit dosing accuracy, ergonomic handling, secure needle interchangeability, and reduced product loss at the point of injection. With granted multi-jurisdictional patent protection, it represents a next-generation drug delivery platform that improves efficiency, reduces cost per dose, and advances standards in injectable administration.